What is the share price of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) today?
The share price of DRAGARWQ as on 29th May 2026 is ₹4966.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
The past returns of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share are- Past 1 week: -3.49%
- Past 1 month: 0.03%
- Past 3 months: 7.97%
- Past 6 months: -13.76%
- Past 1 year: 16.08%
- Past 3 years: 255.19%
- Past 5 years: 1132.38%
What are the peers or stocks similar to Dr Agarwal's Eye Hospital Ltd (DRAGARWQ)?
The peers or stocks similar to Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) include:What is the market cap of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is ₹2400.22 Cr as of 29th May 2026.What is the 52 week high and low of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) share?
The 52-week high of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is ₹6392 and the 52-week low is ₹4142.What is the PE and PB ratio of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) stock?
The P/E (price-to-earnings) ratio of Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) is 34.24. The P/B (price-to-book) ratio is 11.45.Which sector does Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) belong to?
Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) shares?
You can directly buy Dr Agarwal's Eye Hospital Ltd (DRAGARWQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dr Agarwal's Eye Hospital Ltd
DRAGARWQ Share Price
NSE₹4,966.502.46% (-125.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
DRAGARWQ Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
DRAGARWQ Performance & Key Metrics
DRAGARWQ Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.24 | 11.45 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.84 | 6.22 | 0.48% |
DRAGARWQ Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
DRAGARWQ Company Profile
Dr. Agarwal's Eye Hospital Ltd operates eye care hospitals and optical pharmacies across India, providing comprehensive ophthalmology treatments including retina, cornea, cataract, glaucoma, pediatric ophthalmology, and related services.
APOLLOHOSP
PE Ratio
60.55
60.55
1Y Return
18.11%
18.11%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
65.12
65.12
1Y Return
14.98%
14.98%
Buy Reco %
82.61
82.61
FORTIS
PE Ratio
67.28
67.28
1Y Return
29.62%
29.62%
Buy Reco %
83.33
83.33
PE Ratio
47.75
47.75
1Y Return
7.32%
7.32%
Buy Reco %
85.71
85.71
ASTERDM
PE Ratio
97.00
97.00
1Y Return
34.63%
34.63%
Buy Reco %
100.00
100.00
DRAGARWQ Forecast
DRAGARWQ Forecasts
Price
Revenue
Earnings
DRAGARWQ Share Price Forecast
DRAGARWQ Share Price Forecast
2026
Current
₹4,966.50
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹4,966.50
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
DRAGARWQ
DRAGARWQ
Income
Balance Sheet
Cash Flow
Quarterly Normal View
DRAGARWQ Income Statement
DRAGARWQ Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 76.62 | 83.18 | 100.42 | 104.47 | 97.42 | 99.93 | 117.72 | 118.40 | 118.99 | 121.58 | ||||||||||
Operating & Other expenses | 55.18 | 56.28 | 68.61 | 72.31 | 69.49 | 68.24 | 79.79 | 77.64 | 81.85 | 86.28 | ||||||||||
EBITDA | 21.44 | 26.90 | 31.81 | 32.16 | 27.93 | 31.69 | 37.93 | 40.76 | 37.14 | 35.30 | ||||||||||
| Depreciation/Amortization | 6.89 | 7.53 | 9.87 | 9.36 | 10.02 | 10.20 | 10.58 | 11.31 | 11.66 | 12.09 | ||||||||||
| PBIT | 14.55 | 19.37 | 21.94 | 22.80 | 17.91 | 21.49 | 27.35 | 29.45 | 25.48 | 23.21 | ||||||||||
| Interest & Other Items | 1.83 | 2.03 | 3.03 | 3.67 | 3.85 | 2.89 | 4.16 | 3.73 | 2.03 | 1.96 | ||||||||||
| PBT | 12.72 | 17.34 | 18.91 | 19.13 | 14.06 | 18.60 | 23.19 | 25.72 | 23.45 | 21.25 | ||||||||||
| Taxes & Other Items | 3.28 | 4.55 | 4.80 | 4.98 | 3.66 | 2.61 | 5.93 | 6.40 | 6.17 | 5.01 | ||||||||||
| Net Income | 9.44 | 12.79 | 14.11 | 14.15 | 10.40 | 15.99 | 17.26 | 19.32 | 17.28 | 16.24 | ||||||||||
| EPS | 20.09 | 27.21 | 30.02 | 30.11 | 22.13 | 34.02 | 36.72 | 41.04 | 35.76 | 33.60 |
DRAGARWQ Company Updates
DRAGARWQ Stock Peers
DRAGARWQ Past Performance & Peer Comparison
DRAGARWQ Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr Agarwal's Eye Hospital Ltd | 34.24 | 11.45 | — |
| Apollo Hospitals Enterprise Ltd | 60.55 | 10.59 | 0.24% |
| Max Healthcare Institute Ltd | 65.12 | 10.01 | 0.21% |
| Fortis Healthcare Ltd | 67.28 | 7.64 | 0.11% |
DRAGARWQ Stock Price Comparison
Compare DRAGARWQ with any stock or ETFCompare DRAGARWQ with any stock or ETF
DRAGARWQ
DRAGARWQ Holdings
DRAGARWQ Shareholdings
DRAGARWQ Promoter Holdings Trend
DRAGARWQ Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
DRAGARWQ Institutional Holdings Trend
DRAGARWQ Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
DRAGARWQ Shareholding Pattern
DRAGARWQ Shareholding Pattern
DRAGARWQ Shareholding History
DRAGARWQ Shareholding History
Foreign Institutions
Mutual Funds Invested in DRAGARWQ
Mutual Funds Invested in DRAGARWQ
No mutual funds holding trends are available
Top 4 Mutual Funds holding Dr Agarwal's Eye Hospital Ltd
| Funds (Top 4) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0206% | Percentage of the fund’s portfolio invested in the stock 0.53% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 31/32 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0090% | Percentage of the fund’s portfolio invested in the stock 0.22% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 92/93 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.04% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 108/130 (-8) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing DRAGARWQ stock
smallcases containing DRAGARWQ stock
Looks like this stock is not in any smallcase yet.
DRAGARWQ Events
DRAGARWQ Events
DRAGARWQ Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
DRAGARWQ Dividend Trend
No dividend trend available
DRAGARWQ Upcoming Dividends
DRAGARWQ Upcoming Dividends
No upcoming dividends are available
DRAGARWQ Past Dividends
DRAGARWQ Past Dividends
Cash Dividend
Ex DateEx DateNov 7, 2025
Interim
Interim | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Nov 7, 2025
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹3.50
Dividend/Share
₹3.50
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateNov 8, 2024
Interim
Interim | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Nov 8, 2024
Cash Dividend
Ex DateEx DateAug 19, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Aug 19, 2024
Cash Dividend
Ex DateEx DateOct 31, 2023
Interim
Interim | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Oct 31, 2023
DRAGARWQ Stock News & Opinions
DRAGARWQ Stock News & Opinions
Articles & Videos
Corporate
Corporate
Board of Dr Agarwals Eye Hospital recommends final dividendDr Agarwals Eye Hospital announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
1 week agoCapital Market - Live
Earnings
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 1.56% in the March 2026 quarterNet profit of Dr Agarwal's Eye Hospital rose 1.56% to Rs 16.24 crore in the quarter ended March 2026 as against Rs 15.99 crore during the previous quarter ended March 2025. Sales rose 20.21% to Rs 120.01 crore in the quarter ended March 2026 as against Rs 99.83 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.27% to Rs 70.10 crore in the year ended March 2026 as against Rs 54.65 crore during the previous year ended March 2025. Sales rose 18.56% to Rs 470.87 crore in the year ended March 2026 as against Rs 397.15 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales120.0199.83 20 470.87397.15 19 OPM %28.1131.64 -30.8629.84 - PBDT33.3428.80 16 139.25110.15 26 PBT21.2518.60 14 93.6170.70 32 NP16.2415.99 2 70.1054.65 28 Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Eye Hospital to conduct board meetingDr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 20 May 2026.
2 weeks agoCapital Market - Live
Earnings
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 66.15% in the December 2025 quarterNet profit of Dr Agarwal's Eye Hospital rose 66.15% to Rs 17.28 crore in the quarter ended December 2025 as against Rs 10.40 crore during the previous quarter ended December 2024. Sales rose 22.20% to Rs 116.22 crore in the quarter ended December 2025 as against Rs 95.11 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales116.2295.11 22 OPM %29.5726.94 - PBDT35.1124.08 46 PBT23.4514.06 67 NP17.2810.40 66 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Eye Hospital to hold board meetingDr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Earnings
Dr Agarwal's Eye Hospital standalone net profit rises 36.54% in the September 2025 quarterNet profit of Dr Agarwal's Eye Hospital rose 36.54% to Rs 19.32 crore in the quarter ended September 2025 as against Rs 14.15 crore during the previous quarter ended September 2024. Sales rose 15.20% to Rs 117.72 crore in the quarter ended September 2025 as against Rs 102.19 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales117.72102.19 15 OPM %34.0529.24 - PBDT37.0328.49 30 PBT25.7219.13 34 NP19.3214.15 37 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Board of Dr Agarwals Eye Hospital recommends Interim DividendDr Agarwals Eye Hospital announced that the Board of Directors of the Company at its meeting held on 30 October 2025, has recommended a Interim Dividend of Rs.3 per share (i.e.30%), subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Eye Hospital fixes record date for interim dividendDr Agarwals Eye Hospital has fixed 07 November 2025 as record date for the purpose of the interim dividend, if declared. Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Eye Hospital to table resultsDr Agarwals Eye Hospital will hold a meeting of the Board of Directors of the Company on 30 October 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Dr Agarwals Eye Hospital to convene AGMDr Agarwals Eye Hospital announced that the 15th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.63%, vs industry avg of 13.41%
Over the last 5 years, market share increased from 0.43% to 0.49%
Over the last 5 years, net income has grown at a yearly rate of 31.94%, vs industry avg of 42.52%